Medincell SA risk profile
32 Normal where most of the sector sits
Measured 1 September 2026 from MEDCL's filed statements. Recomputed nightly.
32 (Normal), driven by Market expectation at 67, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 67 | Stretched | Volatile | One-year price volatility — 55.8% |
| Operating pressure | 0 | Contained | Easing | Costs outgrowing revenue — -158.1 percentage points |
| Cash conversion | 14 | Contained | Easing | Capital spending against operating cash — 0.09x |
| Leverage and coverage | 40 | Elevated | Easing | Interest cover — -2.20x |
| Competitive position | 45 | Elevated | Stable | Operating-margin gap against peers — -38.7 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.